How to buy Boston Scientific (BSX) shares in Australia
Learn how to easily invest in Boston Scientific shares.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Boston Scientific Corp (BSX) is a leading medical devices business with stocks listed in the US. It opened the day at US$40.38 after a previous close of US$40.43. During the day the price has varied from a low of USD40.125 to a high of USD41.48. The latest price was USD40.86 (25 minute delay). Boston Scientific is listed on the NYSE. All prices are listed in US Dollars.
How to buy shares in Boston Scientific
- Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
- Search for Boston Scientific. Find the share by name or ticker symbol: BSX. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Boston Scientific reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At last close price of US$40.43, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Boston Scientific, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Boston Scientific. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
- Boston Scientific key stats
- Compare share trading platforms
- Is Boston Scientific stock a buy or sell?
- Boston Scientific performance over time
- Is Boston Scientific suitable for ethical investing?
- Are Boston Scientific shares over-valued?
- Boston Scientific's financials
- How volatile are Boston Scientific shares?
- Does Boston Scientific pay a dividend?
- Have Boston Scientific shares ever split?
- Other common questions
Boston Scientific stock price (NYSE:BSX)Use our graph to track the performance of BSX stocks over time.
Boston Scientific shares at a glance
|52-week range||US$34.98 - US$47.5|
|50-day moving average||US$40.3504|
|200-day moving average||US$42.2967|
|Dividend yield||US$0 (0%)|
|Earnings per share (TTM)||US$0.53|
Compare trading apps to buy Boston Scientific shares
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy Boston Scientific stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Boston Scientific price performance over time
|1 week (2022-06-21)||12.56%|
|1 month (2022-05-27)||-0.83%|
|3 months (2022-03-25)||-6.07%|
|6 months (2021-12-27)||-5.24%|
|1 year (2021-06-28)||-5.70%|
|2 years (2020-06-26)||22.78%|
|3 years (2019-06-28)||-4.93%|
|5 years (2017-06-28)||45.31%|
Stocks similar to Boston Scientific
Is Boston Scientific under- or over-valued?
Valuing Boston Scientific stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Boston Scientific's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Boston Scientific's P/E ratio
Boston Scientific's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 72x. In other words, Boston Scientific shares trade at around 72x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Boston Scientific's PEG ratio
Boston Scientific's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.1563. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Boston Scientific's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Boston Scientific's EBITDA
Boston Scientific's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$3.2 billion (£2.6 billion).
The EBITDA is a measure of a Boston Scientific's overall financial performance and is widely used to measure a its profitability.
Boston Scientific financials
|Revenue TTM||US$12.2 billion|
|Operating margin TTM||17.47%|
|Gross profit TTM||US$8.2 billion|
|Return on assets TTM||4.2%|
|Return on equity TTM||4.99%|
|Market capitalisation||US$54.4 billion|
TTM: trailing 12 months
Boston Scientific's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Boston Scientific.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Boston Scientific's total ESG risk score
Total ESG risk: 29.23
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Boston Scientific's overall score of 29.23 (as at 01/01/2019) is nothing to write home about – landing it in it in the 57th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Boston Scientific is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Boston Scientific's environmental score
Environmental score: 1.51/100
Boston Scientific's social score
Social score: 12.87/100
Boston Scientific's governance score
Governance score: 7.87/100
Boston Scientific's controversy score
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Boston Scientific scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Boston Scientific hasn't always managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
|Total ESG score||29.23|
|Total ESG percentile||56.94|
|Level of controversy||3|
Boston Scientific share dividends
We're not expecting Boston Scientific to pay a dividend over the next 12 months.
Have Boston Scientific's shares ever split?
Boston Scientific's shares were split on a 2:1 basis on 6 November 2003. So if you had owned 1 share the day before the split, the next day you would own 2 shares. This wouldn't directly have changed the overall worth of your Boston Scientific shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Boston Scientific shares which in turn could have impacted Boston Scientific's share price.
Boston Scientific share price volatility
Over the last 12 months, Boston Scientific's shares have ranged in value from as little as US$34.98 up to US$47.5. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Boston Scientific's is 0.8172. This would suggest that Boston Scientific's shares are less volatile than average (for this exchange).
Boston Scientific overview
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Frequently asked questions
More guides on Finder
How to buy Nexgen Energy (NXG) shares
Steps to owning and managing Nexgen Energy shares.
How to buy Keypath Education (KED) shares
Steps to owning and managing Keypath Education shares.
What are green bonds and how do they impact the world?
If you want to directly fund climate solutions a green bond is a great place to start. Here is how they work.
5 best ways to invest money in Australia in 2022
What's the best way to invest money in Australia? Find out about robo advisors, index funds, cryptocurrency and more in this guide.
How to buy EBR Systems (EBR) shares
Steps to owning and managing EBR Systems shares.
How to buy 5E Advanced Materials (5EA) shares
Steps to owning and managing 5E Advanced Materials shares.
How to buy Leo lithium shares
Steps to owning and managing Leo lithium shares.
How to buy Besra Gold (BEZ) shares
Steps to owning and managing Besra Gold shares.
How to buy The Lottery Corporation (TLC) shares
Steps to owning and managing The Lottery Corporation shares.
How to buy BSP Financial Group (BFL) shares
Steps to owning and managing Endeavour Group shares.
Ask an Expert